Consulting AgreementConsulting Agreement • August 6th, 2018 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (the “Agreement”) is effective as of March 1, 2018 (the “Effective Date”) and is entered into by and between Dr. Richard L. Lindstrom, an individual (“Consultant”) and Surface Pharmaceuticals, Inc., a Delaware corporation with its principal address located at 12264 El Camino Real, Suite 350, San Diego, CA 92130 (the “Company”).
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • August 6th, 2018 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) dated as of the last date provided for on the signature page hereto (the “Restatement Date”), is entered into between Richard L. Lindstrom, M.D., an individual (“Lindstrom”), with a principal place of business at Minnesota 55391 and Imprimis Pharmaceuticals, Inc., a Delaware corporation (“Imprimis”), with a principal place of business at 12264 El Camino Real, Suite 350, San Diego, California 92130.
